This is due to the induction of phosphorylation in tumor cells by cytotoxic T-cell immunotherapy, which specifically targets the transcription factors signal transducer and activator of transcription 3 (STAT3) and early growth response-1 (EGR-1) and subsequently promotes the formation of CIC. Here, STAT3 is linked to neoplasm.